These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 29277141)
1. In silico studies of conformational dynamics of Mu opioid receptor performed using gaussian accelerated molecular dynamics. Liao JM; Wang YT J Biomol Struct Dyn; 2019 Jan; 37(1):166-177. PubMed ID: 29277141 [TBL] [Abstract][Full Text] [Related]
2. Understanding the molecular basis of agonist/antagonist mechanism of human mu opioid receptor through gaussian accelerated molecular dynamics method. Wang YT; Chan YH Sci Rep; 2017 Aug; 7(1):7828. PubMed ID: 28798303 [TBL] [Abstract][Full Text] [Related]
3. How Oliceridine (TRV-130) Binds and Stabilizes a μ-Opioid Receptor Conformational State That Selectively Triggers G Protein Signaling Pathways. Schneider S; Provasi D; Filizola M Biochemistry; 2016 Nov; 55(46):6456-6466. PubMed ID: 27778501 [TBL] [Abstract][Full Text] [Related]
4. Ligand based conformational space studies of the μ-opioid receptor. Sena DM; Cong X; Giorgetti A Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129838. PubMed ID: 33373630 [TBL] [Abstract][Full Text] [Related]
5. How Does Agonist and Antagonist Binding Lead to Different Conformational Ensemble Equilibria of the κ-Opioid Receptor: Insight from Long-Time Gaussian Accelerated Molecular Dynamics Simulation. An X; Bai Q; Bing Z; Zhou S; Shi D; Liu H; Yao X ACS Chem Neurosci; 2019 Mar; 10(3):1575-1584. PubMed ID: 30372027 [TBL] [Abstract][Full Text] [Related]
6. Computational insights into the molecular mechanisms of differentiated allosteric modulation at the mu opioid receptor by structurally similar bitopic modulators. Wang H; Reinecke BA; Zhang Y J Comput Aided Mol Des; 2020 Aug; 34(8):879-895. PubMed ID: 32193867 [TBL] [Abstract][Full Text] [Related]
7. Atomic-Level Characterization of the Methadone-Stabilized Active Conformation of Kapoor A; Provasi D; Filizola M Mol Pharmacol; 2020 Oct; 98(4):475-486. PubMed ID: 32680919 [TBL] [Abstract][Full Text] [Related]
8. Allosteric modulation model of the mu opioid receptor by herkinorin, a potent not alkaloidal agonist. Marmolejo-Valencia AF; Martínez-Mayorga K J Comput Aided Mol Des; 2017 May; 31(5):467-482. PubMed ID: 28364251 [TBL] [Abstract][Full Text] [Related]
10. Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor. Subramanian G; Paterlini MG; Portoghese PS; Ferguson DM J Med Chem; 2000 Feb; 43(3):381-91. PubMed ID: 10669565 [TBL] [Abstract][Full Text] [Related]
11. Structural and functional interactions between six-transmembrane μ-opioid receptors and β2-adrenoreceptors modulate opioid signaling. Samoshkin A; Convertino M; Viet CT; Wieskopf JS; Kambur O; Marcovitz J; Patel P; Stone LS; Kalso E; Mogil JS; Schmidt BL; Maixner W; Dokholyan NV; Diatchenko L Sci Rep; 2015 Dec; 5():18198. PubMed ID: 26657998 [TBL] [Abstract][Full Text] [Related]
12. An efficient strategy to estimate thermodynamics and kinetics of G protein-coupled receptor activation using metadynamics and maximum caliber. Meral D; Provasi D; Filizola M J Chem Phys; 2018 Dec; 149(22):224101. PubMed ID: 30553249 [TBL] [Abstract][Full Text] [Related]
13. Kinetic and thermodynamic insights into sodium ion translocation through the μ-opioid receptor from molecular dynamics and machine learning analysis. Hu X; Wang Y; Hunkele A; Provasi D; Pasternak GW; Filizola M PLoS Comput Biol; 2019 Jan; 15(1):e1006689. PubMed ID: 30677023 [TBL] [Abstract][Full Text] [Related]